446 related articles for article (PubMed ID: 19108794)
1. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
Iaccheri B; Fiore T; Papadaki T; Androudi S; Janjua S; Bhaila I; Stephen Foster C
Clin Ther; 2008 Nov; 30(11):2069-74. PubMed ID: 19108794
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
3. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].
Colin J; Harie JC
J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556
[TBL] [Abstract][Full Text] [Related]
4. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
[TBL] [Abstract][Full Text] [Related]
5. [Value of clindamycin in the treatment of ocular toxoplasmosis].
Jeddi A; Azaiez A; Bouguila H; Kaoueche M; Malouche S; Daghfous F; Ayed S
J Fr Ophtalmol; 1997; 20(6):418-22. PubMed ID: 9296037
[TBL] [Abstract][Full Text] [Related]
6. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal clindamycin for toxoplasmic retinochoroiditis.
Sobrin L; Kump LI; Foster CS
Retina; 2007 Sep; 27(7):952-7. PubMed ID: 17891023
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
Guelar A; Miró JM; Mallolas J; Zamora L; Cardenal C; Gatell JM; Soriano E
Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):137-40. PubMed ID: 8011719
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment].
Timsit JC; Bloch-Michel E
J Fr Ophtalmol; 1987; 10(1):15-23. PubMed ID: 3598056
[TBL] [Abstract][Full Text] [Related]
10. Clindamycin in the treatment of toxoplasmic retinochoroiditis.
Lakhanpal V; Schocket SS; Nirankari VS
Am J Ophthalmol; 1983 May; 95(5):605-13. PubMed ID: 6846454
[TBL] [Abstract][Full Text] [Related]
11. [Clindamycin therapy of suspected toxoplasmosis retinochoroiditis].
Mittelviefhaus H
Klin Monbl Augenheilkd; 1992 Feb; 200(2):123-7. PubMed ID: 1533697
[TBL] [Abstract][Full Text] [Related]
12. Therapy for ocular toxoplasmosis.
Rothova A; Meenken C; Buitenhuis HJ; Brinkman CJ; Baarsma GS; Boen-Tan TN; de Jong PT; Klaassen-Broekema N; Schweitzer CM; Timmerman Z
Am J Ophthalmol; 1993 Apr; 115(4):517-23. PubMed ID: 8470726
[TBL] [Abstract][Full Text] [Related]
13. [Toxoplasmosis retinochorioiditis, a therapy comparison between spiramycin and pyrimethamine/sulfadiazine].
Hacker M; Richter R; Gümbel H; Richter T; Ohrloff C
Klin Monbl Augenheilkd; 1998 Feb; 212(2):84-7. PubMed ID: 9577806
[TBL] [Abstract][Full Text] [Related]
14. [Toxoplasmosis-chorioretinitis: clinical course and treatment of seven patients].
Lebech AM; Lebech M; Børme KK; Mathiesen LR
Ugeskr Laeger; 1996 Jul; 158(27):3935-9. PubMed ID: 8701510
[TBL] [Abstract][Full Text] [Related]
15. Ocular toxoplasmosis: adverse reactions to treatment in a Brazilian cohort.
Guaraldo L; Villar BBF; Durão NMG; Louro VC; Quintana MSB; Curi ALL; Neves ES
Trans R Soc Trop Med Hyg; 2018 Apr; 112(4):188-192. PubMed ID: 29788193
[TBL] [Abstract][Full Text] [Related]
16. Empiric outpatient therapy with trimethoprim-sulfamethoxazole, cephalexin, or clindamycin for cellulitis.
Khawcharoenporn T; Tice A
Am J Med; 2010 Oct; 123(10):942-50. PubMed ID: 20920697
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations.
Seah SK
J Trop Med Hyg; 1975 Jul; 78(7):150-3. PubMed ID: 1177347
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
[TBL] [Abstract][Full Text] [Related]
19. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
McLeod R; Khan AR; Noble GA; Latkany P; Jalbrzikowski J; Boyer K;
Pediatr Infect Dis J; 2006 Mar; 25(3):270-2. PubMed ID: 16511396
[TBL] [Abstract][Full Text] [Related]
20. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
